$6.620
-0.147 (-2.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EPRX Prediction & Forecast by Similar Chart Analysis
Alphio's EPRX stock price prediction model matches the current Eupraxia Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.58 (-0.56%). The 1-week path is $6.60 (-0.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Eupraxia Pharmaceuticals Inc Stock?
Eupraxia Pharmaceuticals Inc is not a good buy right now due to its current price of $6.62, which is significantly below the analyst price targets of $17 and $25. However, the stock has a low RSI of 27.212, indicating it may be oversold, but the recent 5-day change of -11.26% and widening net losses suggest ongoing financial struggles. The main risk is the projected net loss of $14.5 million for Q2 2026, which raises concerns about the company's financial health.
EPRX stock price ended at $6.62 on Friday, after losing -2.22%
Eupraxia Pharmaceuticals Inc (EPRX) last closed at $6.62, losing -2.22%. These facts feed the 1-day and 1-week EPRX price prediction above.
Forecast Drivers
Eupraxia Pharmaceuticals Inc (EPRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches EPRX, ranked by similarity.
Seasonality analysis for EPRX
Historically the probability of a positive October return for EPRX is 45.76%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EPRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $4.65 | $4.97 | $5.79 | -24.87% |
| Nov 2026 | $4.25 | $5.14 | $5.37 | -22.28% |
| Dec 2026 | $5.49 | $5.70 | $6.53 | -13.84% |
In 2026, Eupraxia Pharmaceuticals Inc (EPRX) is projected to range from $4.25 to $6.53.
Eupraxia Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Eupraxia Pharmaceuticals Inc is projected to average $4.97, with a low of $4.65 and high of $5.79.
In Nov 2026, Eupraxia Pharmaceuticals Inc is projected to average $5.14, with a low of $4.25 and high of $5.37.
In Dec 2026, Eupraxia Pharmaceuticals Inc is projected to average $5.70, with a low of $5.49 and high of $6.53.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.